OXRA-L 10MG/5MG TABLETS | Dapagliflozin Linagliptin Diabetes Guide
OXRA-L 10MG/5MG TABLETS contain Dapagliflozin 10mg and Linagliptin 5mg, a combination antidiabetic medicine prescribed for type 2 diabetes management to help improve blood glucose control.
H1 (20–50 characters)
OXRA-L 10MG/5MG TABLETS
OXRA-L 10MG/5MG TABLETS (DAPAGLIFLOZIN 10MG + LINAGLIPTIN 5MG): Comprehensive Guide and Benefits
Introduction to OXRA-L 10MG/5MG TABLETS
OXRA-L 10MG/5MG: Dual-Action Type 2 Diabetes Therapy
OXRA-L 10MG/5MG TABLETS contain a combination of two oral antidiabetic medicines: Dapagliflozin 10mg and Linagliptin 5mg. It belongs to the SGLT2 inhibitor + DPP-4 inhibitor antidiabetic class and is prescribed for adults with type 2 diabetes mellitus when combination therapy is required along with diet and exercise.
Dapagliflozin helps remove excess glucose through urine, while Linagliptin enhances incretin activity to support glucose regulation. OXRA-L 10MG/5MG TABLETS are prescription-only medicines and should be used under medical supervision.
Key Benefits of OXRA-L 10MG/5MG TABLETS
Helps improve blood glucose control in adults with type 2 diabetes.
Combines two complementary glucose-lowering mechanisms.
Supports elimination of excess glucose through the kidneys.
Helps regulate insulin release, especially after meals.
Provides an oral combination therapy option for patients requiring additional diabetes control.
How OXRA-L 10MG/5MG TABLETS Works
OXRA-L contains two active ingredients:
1. Dapagliflozin 10MG
Dapagliflozin belongs to the SGLT2 inhibitor class.
It blocks the SGLT2 transporter in the kidneys, reducing glucose reabsorption. This allows excess glucose to be eliminated through urine, helping lower blood sugar levels without directly increasing insulin production.
2. Linagliptin 5MG
Linagliptin is a DPP-4 inhibitor.
It increases the activity of incretin hormones, which help regulate blood glucose by supporting insulin release after meals and reducing excess glucose production by the liver.
Together, these medicines provide dual-action management of elevated blood sugar levels.
Usage Instructions for OXRA-L 10MG/5MG TABLETS
Take OXRA-L 10MG/5MG TABLETS exactly as prescribed by your doctor.
Swallow the tablet whole with water.
Do not crush, chew, or break the tablet.
It may be taken with or without food.
Take it at the same time each day for consistent results.
Do not stop treatment without consulting your healthcare provider.
Regular monitoring of blood glucose and kidney function may be advised.
Medicinal Advantages of OXRA-L 10MG/5MG TABLETS
Supports improved glycemic control in type 2 diabetes.
Provides combination therapy in a single tablet.
Helps reduce glucose levels through kidney glucose removal.
Helps improve glucose regulation after meals.
May support long-term diabetes management when combined with lifestyle modifications.
Note: OXRA-L 10MG/5MG TABLETS should be used along with a balanced diet, physical activity, and regular medical follow-up.
Off-Label Uses of OXRA-L 10MG/5MG TABLETS
Dapagliflozin and Linagliptin combinations may be evaluated by specialists for additional applications based on clinical evidence and individual patient conditions.
Possible specialist-guided uses may include:
Individualized metabolic management strategies.
Additional cardiovascular or kidney-related approaches where medically appropriate.
Disclaimer: Off-label use should only be considered under qualified medical supervision.
Expert Advice for Optimal Use
Follow your prescribed dosage schedule carefully.
Maintain adequate hydration unless fluid restriction is advised.
Monitor blood sugar levels regularly.
Maintain proper genital hygiene to reduce infection risk.
Inform your doctor before surgery or prolonged fasting.
Report symptoms such as dizziness, urinary discomfort, weakness, or signs of dehydration.
Precautions
Kidney Function
Inform your doctor if you have kidney disease. Kidney function monitoring may be required because Dapagliflozin acts through the kidneys.
Blood Sugar Monitoring
When used with insulin or insulin-releasing medicines, there may be an increased risk of low blood sugar. Dose adjustment may be required.
Pregnancy & Breastfeeding
Consult your healthcare provider before using OXRA-L during pregnancy or breastfeeding.
Drug Interactions
Inform your doctor if you take:
Insulin or other antidiabetic medicines
Diuretics (water tablets)
Blood pressure medicines
Kidney-related medicines
Herbal supplements
Existing Medical Conditions
Tell your doctor if you have:
Kidney disease
Liver disease
Frequent urinary infections
Dehydration problems
History of diabetic ketoacidosis
Pancreatitis history
Storage Instructions
Store below 30°C.
Keep tablets in the original blister packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is OXRA-L 10MG/5MG TABLETS used for?
A: OXRA-L 10MG/5MG TABLETS are used to improve blood sugar control in adults with type 2 diabetes when treatment with both Dapagliflozin and Linagliptin is appropriate.
Q: What are the active ingredients in OXRA-L 10MG/5MG?
A: The active ingredients are Dapagliflozin 10mg and Linagliptin 5mg.
Q: Is OXRA-L an insulin medicine?
A: No. OXRA-L does not contain insulin. It works by increasing glucose removal through the kidneys and improving incretin-based glucose regulation.
Q: Can OXRA-L 10MG/5MG be taken without prescription?
A: No. OXRA-L is a prescription medicine and should only be taken under medical guidance.
Q: What are common side effects of OXRA-L?
A: Possible side effects may include urinary tract infections, genital fungal infections, low blood sugar (especially with other diabetes medicines), dizziness, weakness, and increased urination.
Q: How does OXRA-L help control diabetes?
A: Dapagliflozin helps remove excess glucose through urine, while Linagliptin helps regulate insulin response and glucose production, providing combined blood sugar control.
Product Tags
OXRA-L 10MG/5MG TABLETS, Dapagliflozin 10mg Linagliptin 5mg, Dapagliflozin Linagliptin Tablet, SGLT2 Inhibitor Medicine, DPP-4 Inhibitor, Type 2 Diabetes Medicine, Antidiabetic Combination Tablet, Blood Sugar Control Medicine, Diabetes Management Tablet, Oral Diabetes Medication, Prescription Diabetes Tablet, Glucose Lowering Therapy, Sun Pharma Diabetes Medicine, OXRA-L Tablet, Metabolic Health Medicine.
